Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Knip

Showing results (311-320 of 321) with videos related to

Pageof 33
Sort By:
Nature Communications|April 17, 2021
Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1A Vuorela, T L Freitag, K Leskinen, et al.
Clinical and Experimental Immunology|October 30, 2019
Circulating β cell-specific CD8<sup>+</sup> T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetesL Yeo, I Pujol-Autonell, R Baptista, et al.
Diabetologia|December 15, 2010
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up, H K Akerblom, J Krischer, et al.
The Journal of Clinical Investigation|June 15, 1996
Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetesH J Aanstoot, S M Kang, J Kim, et al.
Diabetologia|April 20, 2005
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot studyH K Akerblom, S M Virtanen, J Ilonen, et al.
Diabetologia|May 20, 2005
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variationH Viskari, J Ludvigsson, R Uibo, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 1, 2010
Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetesS M Virtanen, S Bärlund, M Salonen, et al.
Allergy|March 21, 2013
Introduction of complementary foods in infancy and atopic sensitization at the age of 5 years: timing and food diversity in a Finnish birth cohortB I Nwaru, H-M Takkinen, O Niemelä, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Clinical and Experimental Immunology|August 16, 2006
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetesB Z Alizadeh, P Hanifi-Moghaddam, P Eerligh, et al.
Pageof 33

Showing results (311-320 of 321) with videos related to

Sort By:
Pageof 33
Nature Communications|April 17, 2021
Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1A Vuorela, T L Freitag, K Leskinen, et al.
Clinical and Experimental Immunology|October 30, 2019
Circulating β cell-specific CD8<sup>+</sup> T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetesL Yeo, I Pujol-Autonell, R Baptista, et al.
Diabetologia|December 15, 2010
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up, H K Akerblom, J Krischer, et al.
The Journal of Clinical Investigation|June 15, 1996
Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetesH J Aanstoot, S M Kang, J Kim, et al.
Diabetologia|April 20, 2005
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot studyH K Akerblom, S M Virtanen, J Ilonen, et al.
Diabetologia|May 20, 2005
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variationH Viskari, J Ludvigsson, R Uibo, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 1, 2010
Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetesS M Virtanen, S Bärlund, M Salonen, et al.
Allergy|March 21, 2013
Introduction of complementary foods in infancy and atopic sensitization at the age of 5 years: timing and food diversity in a Finnish birth cohortB I Nwaru, H-M Takkinen, O Niemelä, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Clinical and Experimental Immunology|August 16, 2006
Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetesB Z Alizadeh, P Hanifi-Moghaddam, P Eerligh, et al.
Pageof 33